C Rad (CRAD B.ST) Stock Price
C Rad Price
Over the last 17 years C Rad grew revenue by 41.0% annually, reaching 441.90 M SEK. Earnings per share have declined at 10.7% per year over the last 7 years. For C Rad, the net margin of 2.4% is down versus 9.6% a few years ago. The consensus 12-month price target for C Rad is 44.88 SEK, about 54.8% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
C Rad stock price
C Rad business model & stock analysis
Frequently asked questions about C Rad
The business model of C Rad AB is focused on providing innovative and advanced medical imaging solutions. C Rad AB is a company that specializes in developing and selling products for the radiation therapy market. They offer a range of solutions including advanced imaging tools and software designed to enhance the accuracy and efficiency of radiation therapy treatments. With a strong commitment to research and development, C Rad AB aims to provide healthcare professionals with cutting-edge technology that improves patient outcomes.
C Rad AB is primarily active in the medical technology industry.
The main competitors of C Rad AB in the market include Elekta AB, Varian Medical Systems Inc., and Accuray Incorporated.
C Rad AB is a Swedish medical technology company that specializes in innovative solutions for cancer treatment. Founded in 2004, C Rad AB has a rich history of developing advanced products for radiation therapy. With a strong focus on improving patient care, the company offers cutting-edge solutions like the C-RAD Catalyst system, which enhances accuracy and efficiency in radiotherapy. The company's commitment to research and development has made C Rad AB a trusted name in the field of oncology. With a vision to revolutionize cancer treatment, C Rad AB continues to make significant contributions to the medical industry through its state-of-the-art technologies and solutions.
C Rad AB has achieved several significant milestones since its inception. The company successfully developed innovative medical solutions, focusing on advanced imaging systems for radiation therapy. C Rad AB has gained notable recognition for its cutting-edge technologies and has received various awards for its exceptional contributions to the field. Additionally, the company has achieved significant collaborations with leading medical institutions and established a global presence by expanding its operations into multiple countries. C Rad AB continues to push boundaries, providing state-of-the-art solutions that enhance precision and safety in radiation therapy treatments.
C Rad AB is primarily present in Sweden.
C Rad AB represents values such as innovation, quality, and sustainability. As a company, C Rad AB is committed to delivering cutting-edge technology and solutions in the field of advanced radiation therapy. With a focus on developing and commercializing innovative products, C Rad AB aims to improve cancer treatment outcomes and enhance patient care. The company's corporate philosophy revolves around continuous research and development, collaboration with healthcare professionals, and a customer-centric approach. C Rad AB strives to make a positive impact on society by providing state-of-the-art solutions that contribute to the advancement of cancer care.
Analysts currently set an average price target of 44.88 SEK for the C Rad stock (median: 44.88 SEK), implying +54.8 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the C Rad stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect C Rad to generate revenue of 463.88 M SEK and earnings per share of 2.28 SEK.
Converted at the current exchange rate, the C Rad share trades at 2.59 EUR (29.00 SEK).
The C Rad share (CRAD B.ST) is listed on 4 stock exchanges, including: London (0R44.L), Frankfurt (24C.F), Stockholm (CRAD B.ST).
The company C Rad AB is a leading provider of digital radiology and medical technology solutions. The company offers a wide range of products and services tailored to the needs of patients, doctors, and hospitals. One of the core divisions of C Rad AB is the development and manufacture of digital radiology systems, including Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and digital X-ray systems. These systems are capable of creating precise images of tissues and organs while enabling minimally invasive treatments. C Rad AB aims to improve patient care by focusing on the development of systems that enable precise and fast diagnoses. Another important business area is the development of medical software solutions. C Rad AB has developed a range of tools for digitally capturing, archiving, and analyzing radiological images. These analysis tools allow radiologists to make fast diagnoses and plan effective treatments. The software solutions also include a platform for data exchange and collaboration, making it easier for doctors and clinics to share patient images and data. C Rad AB also operates a number of diagnostic centers that offer a comprehensive range of health services. These centers provide rapid tests, radiology services, laboratory diagnostics, and other medical services. The centers are equipped with state-of-the-art technology and provide fast and accurate diagnoses for patients. Finally, C Rad AB also offers a variety of training and support services for patients and medical professionals. The company operates its own training academy, offering training for radiologists and medical personnel. Additionally, the company provides technical support and maintenance services for its products. Overall, the business model of C Rad AB is focused on offering innovative solutions for radiology and digital medicine. The company has a strong research and development department that is constantly working on new technologies and solutions. By combining top-quality products, services, and training, C Rad AB has strengthened its position as a leading provider of medical technology solutions.
The expected revenue of C Rad is 463.88 M SEK. This figure is based on current financial data and reflects the company's business performance.
The expected profit of C Rad is 77.23 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of C Rad is currently 12.69. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the C Rad stock.
The price-to-sales ratio (P/S) of C Rad is currently 2.11. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the C Rad stock.
The Eulerpool Quality Score for C Rad is 5/10.
The ISIN of C Rad is SE0002016352. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of C Rad is A0X93X. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of C Rad is CRAD B.ST. The ticker symbol is used to trade C Rad shares on the stock exchange.
C Rad stock
C Rad Ticker
C Rad FIGI
All fundamentals and in-depth analysis of C Rad
Our stock analysis for C Rad stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of C Rad. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.